Open AccessHistone deacetylase inhibitor sodium butyrate regulates the activation of toll-like receptor 4/interferon regulatory factor-3 signaling pathways in prostate cancer cells
Author(s) -
AsumanDeveci Ozkan,
GamzeGuney Eskiler,
Nur Kazan,
Özge Turna
Publication year - 2022
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/jcrt.jcrt_2032_21
Subject(s) - sodium butyrate , lncap , histone deacetylase , irf3 , interferon regulatory factors , cancer research , histone deacetylase inhibitor , histone deacetylase 2 , viability assay , signal transduction , apoptosis , biology , microbiology and biotechnology , chemistry , cancer cell , receptor , cell culture , histone , cancer , biochemistry , innate immune system , genetics , gene